Anti-ITGA9 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an anti-α9 integrin antibody, exerts a therapeutic effect on cancer, for example proliferation and metastasis of a cancer cell, and an inflammatory disease, for example rheumatoid arthritis, osteoarthritis, hepatitis, bronchial asthma, fibrosis, diabetes, arteriosclerosis, multiple sclerosis, granuloma, an inflammatory bowel disease (ulcerative colitis and Crohn's disease), an autoimmune disease and the like by inhibiting the α9 integrin function.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-736LC | Human Anti-ITGA9 Recombinant Antibody (TAB-736LC) | ELISA | Chimeric (mouse/human) IgG |
TAB-736LC-S(P) | Mouse Anti-ITGA9 Recombinant Antibody; scFv Fragment (TAB-736LC-S(P)) | ELISA | Mouse scFv |
TAB-736LC-F(E) | Human Anti-ITGA9 Recombinant Antibody; Fab Fragment (TAB-736LC-F(E)) | ELISA | Chimeric antibody (mouse/human) |
There are currently no Customer reviews or questions for AFC-439CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.